Social Network
FDA approves new prostate cancer imaging tool, company says
May 28 2021, 08:00
The company behind an imaging agent meant to identify prostate cancer said it received FDA approval on Thursday for use in patients with suspected metastasis or recurrence.
Source: FOX News
Back to news
Related news
Lawyer leading SJSU transgender lawsuit reacts to controversial probe into trans athlete's alleged misconduct
I lost my 16-year-old son to suicide from addictive AI algorithms. We can't let Big Tech destroy our children
Author floats 'fascinating' possibility of Caitlin Clark being focal point of breakaway basketball league
Family of victim and survivors of Indianapolis FedEx mass shooting file lawsuit against gun magazine manufacturer and distributors
Tennessee Air National Guardsman applied to be a hitman online, the FBI says. It was a spoof website and now he's facing charges
Fulton County, Georgia, jail leadership resigns after inmate's death and accusations of unsanitary conditions
Big-box stores could help slash emissions and save millions by putting solar panels on roofs. Why aren't more of them doing it?
Not only is Lake Powell's water level plummeting because of drought, its total capacity is shrinking, too
Michelle Obama's podcast puts her in limelight in new Trump era, but she's not coming to Democrats' rescue
Lawyer leading SJSU transgender lawsuit reacts to controversial probe into trans athlete's alleged misconduct